Clobazam (Q36697498)

15 August 2017

1 reference

title

Clobazam. (English)

1 reference

15 August 2017

Yu-tze Ng

1 reference

15 August 2017

Stephen D Collins

series ordinal

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

138-144

1 reference

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Lennox-Gastaut syndrome (childhood epileptic encephalopathy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

21 January 2018

Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Nonpharmacologic treatment of the catastrophic epilepsies of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Clobazam as a new antiepileptic drug and clorazepate dipotassium as an alternative antiepileptic drug in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Anticonvulsant activity in photosensitive baboons, Papio papio, of two new 1,5 benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Anticonvulsant Action of a 1,5-Benzodiazepine, Clobazam, in Reflex Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Mechanism of clobazam-induced thyroidal oncogenesis in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Pharmacokinetics of single and multiple doses of clobazam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Clobazam kinetics: intrasubject variability and effect of food on adsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

No effect of food intake on clobazam absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Benzodiazepines in the treatment of children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Effects of age and antiepileptic drugs on plasma levels and kinetics of clobazam and N-desmethylclobazam

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Clobazam monotherapy in drug naïve adult patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe(+++)-induced epileptic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

A pharmacological profile of clobazam (Mystan), a new antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Antiepileptic Properties of Clobazam, a 1–5 Benzodiazepine, in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Open study of clobazam in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Intermittent clobazam for catamenial epilepsy: tolerance avoided

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Use of clobazam for the treatment of refractory complex partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Factors relating to dramatic response to clobazam therapy in refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

The long-term effect of clobazam as adjunctive therapy in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Interactions of clobazam with conventional antiepileptics in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Clobazam in Treatment of Refractory Epilepsy: The Canadian Experience. A Retrospecti

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.002

Clobazam in the treatment of epilepsy: prospective follow-up to 8 years

21 January 2018

1 reference

12 December 2020

Usefulness of clobazam in the treatment of refractory epilepsy in children

1 reference

12 December 2020

Clobazam for refractory focal epilepsy. A controlled trial

1 reference

12 December 2020

Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy

1 reference

12 December 2020

Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group

1 reference

12 December 2020

Clobazam in Long‐Term Epilepsy Treatment: Sustained Responders Versus Those Developing Tolerance

1 reference

12 December 2020

The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy

1 reference

12 December 2020

Monotherapy with clobazam in epilepsies in children

1 reference

12 December 2020

Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants

1 reference

12 December 2020

Add-on trial of clobazam in intractable adult epilepsy with plasma level correlations

1 reference

12 December 2020

Clobazam as adjunctive treatment in refractory epilepsy

1 reference

12 December 2020

Clobazam in the treatment of epilepsy.

1 reference

12 December 2020

Clobazam for the treatment of intractable childhood epilepsy

1 reference

12 December 2020

In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.

1 reference

12 December 2020

Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood.

1 reference

12 December 2020

[Clobazam in refractory epilepsies of children]

1 reference

12 December 2020

Antiepileptic effects of clobazam in children.

1 reference

12 December 2020

Anti-epileptic effect of clobazam in Lennox-Gastaut syndrome (author's transl)

1 reference

12 December 2020

Clinical experience with clobazam: a new 1,5 benzodiazepine in the treatment of refractory epilepsy

1 reference

12 December 2020

Study of an anxiolytic, clobazam, in otorhinolaryngology in psychosomatic pharyngeal manifestations

1 reference

12 December 2020

Monitoring of concentrations of clobazam and norclobazam in serum and saliva of children with epilepsy

1 reference

12 December 2020

The anti-epileptic properties of a diazepine drug (clobazam). Preliminary results

1 reference

12 December 2020

Clobazam for refractory childhood seizure disorders--a valuable supplementary drug

1 reference

12 December 2020

Clobazam as adjunctive treatment in drug resistant epilepsy--report on an open prospective study.

1 reference

12 December 2020

Pharmacokinetic aspects of the interaction between clobazam and cimetidine

1 reference

12 December 2020

10.1016/J.NURT.2006.11.002

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1032660334

0 references

PMC publication ID

7479695

0 references

1 reference